Ophthalmic Viscosurgical Devices Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Name: Ophthalmic Viscosurgical Devices Market
SKU: Life Sciences
Rating: 4.8 (5 reviews)

Coverage: Ophthalmic Viscosurgical Devices Market covers analysis By Product (Dispersive, Cohesive, Combined), Application (Cataract Surgery, Refractive Surgery, Vitreoretinal Surgery, Keratoplasty), End-user (Hospitals, Diagnostic Centers, Eye Specialty Clinics, Others) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

Report Code : TIPHE100001311
Category : Life Sciences

Status : Upcoming
No. of Pages : 150

Buy Now

MARKET OVERVIEW

phthalmic viscosurgical devices (OVDs) or viscoelastic agents are essential tools for the anterior segment surgeon. The anterior segment surgeon requires ophthalmic viscosurgical devices (OVDs) or viscoelastic agents. OVDs are viscous and elastic solids that are translucent and gel-like. They are made up of sodium hyaluronate, chondroitin sulphate, and methylcellulose and come in a variety of molecular weights and viscosities. They are divided into two types cohesive and dispersive. OVDs are utilized to maintain and conserve space, displace and stabilize tissue, and coat and protect tissue during surgery. During cataract surgery, these roles include preserving the anterior chamber during capsulorhexis and IOL implantation, preventing iris prolapse, and trapping the iris. Ophthalmic Viscosurgical Devices (OVDs) are widely used as a surgical aid for performing ocular surgeries such as cataract, glaucoma, vitrectomy, and others.

MARKET SCOPE

The "Ophthalmic Viscosurgical Devices Market to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Ophthalmic Viscosurgical Devices Market with detailed market segmentation by of Type, Application, Source and End Users. The Ophthalmic Viscosurgical Devices Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Ophthalmic Viscosurgical Devices Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

n the basis of Type, the market is segmented into Dispersive, Cohesive, Combined.
n the basis of Application the market is segmented into Cataract Surgery, Vitreoretinal Surgery, Refractive Surgery, Keratoplasty.
n the basis of Source, the market is segmented into Animal, Biological, Semi-Synthetic
n the basis of End Users is segmented into Hospitals, Diagnostic Centers, Eye Specialty Clinics, Others.

MARKET DYNAMICS

Drivers

The increasing prevalence of ocular diseases such as cataracts, glaucoma, and other vision-related problems, and rising geriatric population, prevalence of diabetes, ophthalmic viscosurgical devices are becoming more popular. Furthermore, technical improvements in the industry will increase its global acceptance rate.
In addition, the Ophthalmic Viscosurgical Devices market has seen the presence of strong products in the pipeline. create new opportunities for the Ophthalmic Viscosurgical Devices Marketover the forecast period.

Restraints

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Ophthalmic Viscosurgical Devices Marketbased on various segments. It also provides market size and forecast estimates from year 2017 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Ophthalmic Viscosurgical Devices Marketby each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Ophthalmic Viscosurgical Devices Marketfrom both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the Ophthalmic Viscosurgical Devices Marketin these regions.

IMPACT OF COVID-19 ON CELL SEPARATION SYSTEMS MARKET:

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. The global impacts of the COVID-19 are already starting to be felt, and will significantly affect the Ophthalmic Viscosurgical Devices Marketin 2021.Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the Ophthalmic Viscosurgical Devices Marketas organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Ophthalmic Viscosurgical Devices Marketare anticipated to have lucrative growth opportunities in the future with the rising demand for Ophthalmic Viscosurgical Devices Marketin the global market. Below mentioned is the list of few companies engaged in the Cell Separation Systems Market.

The report also includes the profiles of key players in Ophthalmic Viscosurgical Devices Marketalong with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

Abbott Medical Optics, Inc.,

Carl-Zeiss AG,

Novartis International AG

Johnson & Johnson Vision Care, Inc.,

F. Hoffmann-La Roche Ltd.,

Pfizer, Inc.,

Allergan, Inc

Hyaltech Ltd.,

CIMA Technology, Inc

Rayner

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Ophthalmic Viscosurgical Devices Report Scope

Report Attribute	Details
Market size in 2023	US$ XX Million
Market Size by 2031	US$ XX Million
Global CAGR (2023 - 2031)	XX%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Product Dispersive Cohesive Combined By Application Cataract Surgery Refractive Surgery Vitreoretinal Surgery Keratoplasty By End-user Hospitals Diagnostic Centers Eye Specialty Clinics
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Abbott Medical Optics, Inc., Carl-Zeiss AG, Novartis International AG Johnson & Johnson Vision Care, Inc., F. Hoffmann-La Roche Ltd., Pfizer, Inc., Allergan, Inc., Hyaltech Ltd., Valeant Pharmaceuticals International, Inc.